Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Eyelashes protect the eyes, but more research is needed to understand how.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Consider benefits and risks of new alopecia treatments for safety.

Microneedling is a safe and effective way to improve various skin conditions with minimal side effects.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Japan improved its regulation of regenerative medicine to ensure safety and prevent unproven treatments.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.